Pfizer Detrol Patent Still Enforceable: Judge

By Christie Smythe (April 14, 2009, 12:00 AM EDT) -- A federal judge has shot down Ivax Pharmaceuticals Inc.'s request to reconsider findings that Pfizer Inc. did not intend to deceive the U.S. Patent and Trademark Office in seeking to patent ingredients for its bladder control drug Detrol, hurting Ivax's efforts to sell a generic form of the drug before the patent expires....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!